SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-19-002276
Filing Date
2019-03-05
Accepted
2019-03-05 09:00:41
Documents
8
Period of Report
2019-02-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K v030519_8k.htm 8-K 51783
2 EXHIBIT 10.1 v030519_ex101.htm EX-10.1 280580
3 EXHIBIT 10.2 v030519_ex102.htm EX-10.2 589747
4 EXHIBIT 10.3 v030519_ex103.htm EX-10.3 123227
5 EXHIBIT 10.4 v030519_ex104.htm EX-10.4 125770
6 EXHIBIT 5.1 v030519_ex5-1.htm EX-5.1 20197
7 IMAGE ablogosm3.jpg GRAPHIC 7046
8 IMAGE tgtherapeutics_hercules-l000.jpg GRAPHIC 84972
  Complete submission text file 0001654954-19-002276.txt   1319755
Mailing Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014 (212) 554-4484
TG THERAPEUTICS, INC. (Filer) CIK: 0001001316 (see all company filings)

IRS No.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32639 | Film No.: 19656785
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences